Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Galapagos NV (GLPG)

127.65   3.97 (3.21%) 10-23 23:03
Open: 126.61 Pre. Close: 123.68
High: 128.935 Low: 126.07
Volume: 118,878 Market Cap: 8,355M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 129.089 - 129.567 129.567 - 129.952
Low: 124.775 - 125.379 125.379 - 125.865
Close: 126.744 - 127.676 127.676 - 128.425

Technical analysis

as of: 2020-10-23 4:44:23 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 161.50     One year: 173.66
Support: Support1: 121.42    Support2: 101.02
Resistance: Resistance1: 138.27    Resistance2: 148.68
Pivot: 137.12
Moving Average: MA(5): 127.32     MA(20): 138.32
MA(100): 168.36     MA(250): 192.36
MACD: MACD(12,26): -4.29     Signal(9): -2.73
Stochastic oscillator: %K(14,3): 10.89     %D(3): 10.76
RSI: RSI(14): 39.40
52-week: High: 274.03  Low: 112.00  Change(%): -27.3
Average Vol(K): 3-Month: 16321  10-Days: 16052

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GLPG has closed above bottom band by 22.1%. Bollinger Bands are 10.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Oct 2020
Galapagos Is A Buy Despite Setback In The U.S. - Seeking Alpha

Fri, 23 Oct 2020
7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio -

Thu, 22 Oct 2020
Pre-earnings Bullish Momentum Pattern and Trigger in Galapagos NV - - CML News

Sun, 18 Oct 2020
Galapagos Knee Osteoarthritis Data, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha

Sun, 18 Oct 2020
$232.82 Million in Sales Expected for GALAPAGOS NV/S (NASDAQ:GLPG) This Quarter - MarketBeat

Sat, 17 Oct 2020
GALAPAGOS NV/S (NASDAQ:GLPG) Rating Increased to Strong-Buy at ValuEngine - MarketBeat

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 65
Shares Float (M) 42
% Held by Insiders
% Held by Institutions 11.71
Shares Short (K) 1,090
Shares Short P. Month (K) 1,110

Stock Financials

EPS -1.690
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 25.490
Profit Margin 7.92
Operating Margin
Return on Assets (ttm) 5.8
Return on Equity (ttm) 4.1
Qtrly Rev. Growth 74.1
Gross Profit (p.s.) 7.171
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -75.53
PEG Ratio
Price to Book value 5.01
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.